CALLOS ANDREW (Chief Commercial Officer) sold 11.3% of their position (7.45K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $491.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/15/2026ACC: 0001061983-26-000036
Officer· Chief Commercial Officer
Since Mar 2021
-7.45K
Net shares
Net seller
$491.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.45K
Price / share
$66.02
Trade value
$491.78K
% of position
11.3%
4/15/2026
66K→58.55K
Total
Net shares
−7.45K
Net value
-$491.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | S · Sale | −7.45K | $66.02 | $491.78K | 11.3% | 66K | 58.55K |
| Total | −7.45K | -$491.78K | ||||||
Derivative Transactions0
No derivative transactions reported